Crow Point Partners’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-573
| Closed | -$50K | – | 125 |
|
|
2018
Q4 | $50K | Hold |
573
| – | – | 0.01% | 116 |
|
|
2018
Q3 | $267K | Buy |
573
+44
| +8% | +$20.5K | 0.05% | 121 |
|
|
2018
Q2 | $204K | Buy |
529
+517
| +4,308% | +$199K | 0.04% | 110 |
|
|
2018
Q1 | $4K | Sell |
12
-52
| -81% | -$17.3K | ﹤0.01% | 258 |
|
|
2017
Q4 | $20K | Buy |
+64
| New | +$20K | ﹤0.01% | 245 |
|